Cargando…
Gene Therapy for Huntington’s Disease: The Final Strategy for a Cure?
Huntington’s disease (HD) has become a target of the first clinical trials for gene therapy among movement disorders with a genetic origin. More than 100 clinical trials regarding HD have been tried, but all failed, although there were some improvements limited to symptomatic support. Compared to ot...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Movement Disorder Society
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820879/ https://www.ncbi.nlm.nih.gov/pubmed/34781633 http://dx.doi.org/10.14802/jmd.21006 |